Home > Quotes > FBT

First Trust Amex Biotechnology Index Fund Stock Quote & Summary Data

(ETF)
FBT 
$103.41
*  
2.48
2.46%
Get FBT Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading FBT now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
ETF Details
Summary Quote ETF Detail Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
ETF NEWS
ETF Headlines Market Stream
FUNDAMENTALS
Short Interest Dividend History
 Save Stocks
1 Year Target
Today's High /Low  / 
Share Volume
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 158,967
Previous Close $ 100.93
52 Week High/Low $ 105.9207 / $ 67.27
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 1,582,173,207
Annualized dividend $ 0.2096
Ex Dividend Date Dec. 23, 2014
Dividend Payment Date Dec. 31, 2014
Current Yield 0.21 %
Beta 0

Intraday Chart

Description

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. The index is rebalanced quarterly based on closing prices on the third Friday in January, April, July & October to ensure that each component stock continues to represent approximately equal weight in the index.


Underlying Index NYSE Arca Biotechnology Index
Management Fee 0.6
Asset Class Equity
Leverage 1
Top Holdings
ITMN Intermune Inc 6.96%
VRTX Vertex Pharmaceuticals Inc 6.47%
EXAS Exact Sciences Corp 5.64%
INCY Incyte Corp 5.56%
ILMN Illumina Inc 5.53%
CELG Celgene Corp 5.39%
QGEN Qiagen N.V. 5.22%
NKTR Nektar Therapeutics 5.2%
GILD Gilead Sciences 5.13%
BIIB Biogen Idec Inc 4.8%

Research Brokers before you trade

Want to trade FX?